Naibio Tech. Co., Ltd. is a global leader in AI-driven synthetic biotechnology. By leveraging cutting-edge nanotechnology and artificial intelligence algorithms, we decode protein structures and functions at the molecular and genetic level, developing groundbreaking synthetic biology products to revolutionize healthcare, industry, and environmental solutions.
NAIBIO is dedicated to integrating artificial intelligence with nanotechnology to build the next generation of synthetic biology technologies. Our team of world-class scientists and engineers has developed core technologies, including quantum computing for protein folding prediction, nanoscale gene editing tools, and high-throughput molecular synthesis platforms, advancing life sciences to new frontiers.
Utilizing atomic force microscopy and nanorobotics, we achieve precise protein assembly at the nanoscale, significantly enhancing synthesis efficiency and biocompatibility.
Powered by generative adversarial networks and reinforcement learning, we simulate billions of protein variants, predict their functions, and select optimal candidates, reducing R&D timelines to a fraction of traditional methods.
NAIBIO’s core technologies combine AI, nanotechnology, and synthetic biology, representing the forefront of life sciences.
Using quantum algorithms to simulate protein folding with sub-angstrom precision, addressing complex structural prediction challenges beyond traditional computational methods.
Developing ultra-precise nanoscale gene editing tools for single-base targeted modifications, ushering in a new era of gene therapy.
Integrating AI optimization with automated synthesis equipment to create an efficient closed-loop process from design to production, yielding millions of molecular candidates annually.
NAIBIO’s technologies are widely applied in healthcare, industry, and environmental sectors, addressing global challenges.
Designing synthetic protein drugs targeting cancer for personalized treatments, significantly improving efficacy and reducing side effects.
Developing synthetic microbes to convert carbon dioxide into biofuels, providing innovative solutions for carbon neutrality.
Using nanobiosensors to monitor pollutants and synthetic microbes to degrade toxic substances, restoring ecological balance.
The NAI.Bio platform is our proprietary AI and nanotechnology fusion tool, integrating molecular dynamics simulation, gene sequence analysis, and interactive protein design, with cloud-based quantum computing optimization, leading the future of synthetic biology.
NOxLabs is a joint laboratory established by NAIBIO and Oxford University, focusing on targeted cancer therapies, high-performance biomaterials, and sustainable biotechnology. It has published groundbreaking results in top journals like Nature.
Developed AI-driven synthetic enzymes to efficiently convert carbon dioxide into biofuels, securing multiple international patents.
Developing next-generation nanobiosensors for real-time health monitoring, driving the precision medicine revolution.
We welcome you to contact us to explore collaboration opportunities or learn more about our work.
info@naibio.com
Room 205, 2nd Floor, No. 2 Fuqiang Road, Daxing District, Beijing, China